|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-12-9
|
|
pubmed:abstractText |
Human epidermal growth factor receptor 2 (HER2) is regarded as a poor prognostic factor in many tumors. Conflicting data in many literatures were reported about the association between HER2 and poor prognosis in lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1922-32
|
|
pubmed:meshHeading |
pubmed-meshheading:21155183-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21155183-Carcinoma, Small Cell,
pubmed-meshheading:21155183-Gene Amplification,
pubmed-meshheading:21155183-Humans,
pubmed-meshheading:21155183-Immunohistochemistry,
pubmed-meshheading:21155183-In Situ Hybridization, Fluorescence,
pubmed-meshheading:21155183-Lung Neoplasms,
pubmed-meshheading:21155183-Mutation,
pubmed-meshheading:21155183-Prognosis,
pubmed-meshheading:21155183-Publication Bias,
pubmed-meshheading:21155183-Receptor, erbB-2
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
|
|
pubmed:affiliation |
Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
